JANSSEN PHARMACEUTICA N.V.
Date updated: 2026-04-19
TOTAL PRODUCT APPROVED: 12
Overview
Product Registered
Categories
Type of Products
Analysis
Product Holder
| Product holder name | Product count |
|---|---|
| 11 | |
| 1 |
Product count11
Product count1
Rows per page:
1–2 of 2
Analysis
Product API
| Ingredient (API) name | Product count |
|---|---|
| 8 | |
| 1 | |
| 1 | |
| 1 | |
| 1 |
Product count8
Product count1
Product count1
Product count1
Product count1
Rows per page:
1–5 of 5
Related Articles
An introduction to AIPharm - Making Good Pharmaceutical Data Accessible to Everyone
Manfye Goh · 2 min read
Bridging the Gap: Assessing Hypertension Drug Availability and Alignment with Malaysian CPG Guidelines and MOH Formulary
Manfye Goh · 12 min read
The 2022 New Health Supplement Products Analysis
Manfye Goh · 6 min read
Listing
Registered Product
| Product name | Product Reg. no | Type | Product Holder | Manufacturer | Importer | Registration Status |
|---|---|---|---|---|---|---|
| NIZORAL CREAM | MAL19921254AZ | NEW CHEMICAL ENTITY | JOHNSON & JOHNSON SDN. BHD. | JANSSEN PHARMACEUTICA N.V. | JOHNSON & JOHNSON SDN. BHD. | PRODUCT APPROVED |
| MOTILIUM ORAL SUSPENSION 1MG/ML | MAL19872253AZ | NEW CHEMICAL ENTITY | JOHNSON & JOHNSON SDN. BHD. | JANSSEN PHARMACEUTICA N.V. | JOHNSON & JOHNSON SDN. BHD. | PRODUCT APPROVED |
| DAKTARIN CREAM 2% | MAL19900260AZ | NEW CHEMICAL ENTITY | JNTL (MALAYSIA) SDN. BHD. | JANSSEN PHARMACEUTICA N.V. | JNTL (MALAYSIA) SDN. BHD. | PRODUCT APPROVED |
| RISPERDAL ORAL SOLUTION 1MG/ML | MAL19992548AZ | NEW CHEMICAL ENTITY | JOHNSON & JOHNSON SDN. BHD. | JANSSEN PHARMACEUTICA N.V. | JOHNSON & JOHNSON SDN. BHD. | PRODUCT APPROVED |
| INVEGA TRINZA 263mg/1.315mL Prolonged-Release Suspension for Intramuscular Injection | MAL20046068AZ | NEW CHEMICAL ENTITY | JOHNSON & JOHNSON SDN. BHD. | JANSSEN PHARMACEUTICA N.V. | JOHNSON & JOHNSON SDN. BHD. | PRODUCT APPROVED |
| INVEGA TRINZA 525mg/2.625mL Prolonged-Release Suspension for Intramuscular Injection | MAL20046070AZ | NEW CHEMICAL ENTITY | JOHNSON & JOHNSON SDN. BHD. | JANSSEN PHARMACEUTICA N.V. | JOHNSON & JOHNSON SDN. BHD. | PRODUCT APPROVED |
| INVEGA TRINZA 350mg/1.750mL Prolonged-Release Suspension for Intramuscular Injection | MAL20046069AZ | NEW CHEMICAL ENTITY | JOHNSON & JOHNSON SDN. BHD. | JANSSEN PHARMACEUTICA N.V. | JOHNSON & JOHNSON SDN. BHD. | PRODUCT APPROVED |
| INVEGA TRINZA 175mg/0.875mL Prolonged-Release Suspension for Intramuscular Injection | MAL20046067AZ | NEW CHEMICAL ENTITY | JOHNSON & JOHNSON SDN. BHD. | JANSSEN PHARMACEUTICA N.V. | JOHNSON & JOHNSON SDN. BHD. | PRODUCT APPROVED |
NIZORAL CREAM
Product Reg. noMAL19921254AZ
TypeNEW CHEMICAL ENTITY
Product HolderJOHNSON & JOHNSON SDN. BHD.
ManufacturerJANSSEN PHARMACEUTICA N.V.
ImporterJOHNSON & JOHNSON SDN. BHD.
Registration StatusPRODUCT APPROVED
MOTILIUM ORAL SUSPENSION 1MG/ML
Product Reg. noMAL19872253AZ
TypeNEW CHEMICAL ENTITY
Product HolderJOHNSON & JOHNSON SDN. BHD.
ManufacturerJANSSEN PHARMACEUTICA N.V.
ImporterJOHNSON & JOHNSON SDN. BHD.
Registration StatusPRODUCT APPROVED
DAKTARIN CREAM 2%
Product Reg. noMAL19900260AZ
TypeNEW CHEMICAL ENTITY
Product HolderJNTL (MALAYSIA) SDN. BHD.
ManufacturerJANSSEN PHARMACEUTICA N.V.
ImporterJNTL (MALAYSIA) SDN. BHD.
Registration StatusPRODUCT APPROVED
RISPERDAL ORAL SOLUTION 1MG/ML
Product Reg. noMAL19992548AZ
TypeNEW CHEMICAL ENTITY
Product HolderJOHNSON & JOHNSON SDN. BHD.
ManufacturerJANSSEN PHARMACEUTICA N.V.
ImporterJOHNSON & JOHNSON SDN. BHD.
Registration StatusPRODUCT APPROVED
INVEGA TRINZA 263mg/1.315mL Prolonged-Release Suspension for Intramuscular Injection
Product Reg. noMAL20046068AZ
TypeNEW CHEMICAL ENTITY
Product HolderJOHNSON & JOHNSON SDN. BHD.
ManufacturerJANSSEN PHARMACEUTICA N.V.
ImporterJOHNSON & JOHNSON SDN. BHD.
Registration StatusPRODUCT APPROVED
INVEGA TRINZA 525mg/2.625mL Prolonged-Release Suspension for Intramuscular Injection
Product Reg. noMAL20046070AZ
TypeNEW CHEMICAL ENTITY
Product HolderJOHNSON & JOHNSON SDN. BHD.
ManufacturerJANSSEN PHARMACEUTICA N.V.
ImporterJOHNSON & JOHNSON SDN. BHD.
Registration StatusPRODUCT APPROVED
INVEGA TRINZA 350mg/1.750mL Prolonged-Release Suspension for Intramuscular Injection
Product Reg. noMAL20046069AZ
TypeNEW CHEMICAL ENTITY
Product HolderJOHNSON & JOHNSON SDN. BHD.
ManufacturerJANSSEN PHARMACEUTICA N.V.
ImporterJOHNSON & JOHNSON SDN. BHD.
Registration StatusPRODUCT APPROVED
INVEGA TRINZA 175mg/0.875mL Prolonged-Release Suspension for Intramuscular Injection
Product Reg. noMAL20046067AZ
TypeNEW CHEMICAL ENTITY
Product HolderJOHNSON & JOHNSON SDN. BHD.
ManufacturerJANSSEN PHARMACEUTICA N.V.
ImporterJOHNSON & JOHNSON SDN. BHD.
Registration StatusPRODUCT APPROVED
Rows per page:
1–8 of 12